Low-income patients' access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found.

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.

A more tragic irony in the town is an obesity crisis among residents living in the shadow of the massive Wegovy-making plant.

Scott Disick's gaunt appearance sparked concerns about his health after he started using weight-loss medications ...

Mason Disick is helping dad Scott Disick live a healthier lifestyle. According to a source, ever since the 14-year-old has ...

COMEDIAN Marcus Brigstocke has revealed he became hooked on porn after cheating on his wife. The Love Actually star, 51, ...

Researchers have found "tremendous long-term outcomes" for teenagers who underwent surgery to treat their severe obesity a ...

Supplements for muscle growth (often called "ergogenic aids") may be used to help you "bulk up," improve athletic performance ...

New weight-loss jabs available through the NHS are being hailed as “game-changing”, but they are not a magic fix for ...

The updated AAP clinical guidelines on obesity treatment recommend offering the full spectrum of care upon initial obesity ...

The safety and effectiveness of QSYMIA in combination with other products intended for weight loss, including prescription ...

CAMPBELL, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- VIVUS announced today that the U.S. Food and Drug Administration has removed the requirement for a cardiovascular outcome trial for its ...